Institutional Ownership Keros Therapeutics, Inc. (KROS)
This table provides information about the institutional ownership of Keros Therapeutics, Inc. (KROS). We have compiled data on the 177 institutions that hold shares in the stock, with a total of 36.3 Million shares, which have been reported (via 13F filing form) to have a value of $512 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Nuveen, LLC
Charlotte, NC |
May 12, 2025 Q1 2025 |
3,947,455
shares
|
$55.7 Million
0.01% of portfolio
|
Q1 2025
New holding
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
2,600,457
shares
|
$36.7 Million
0.0% of portfolio
|
Q1 2025
Added 1118.41%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
2,566,321
shares
|
$36.2 Million
0.0% of portfolio
|
Q1 2025
Added 31.13%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,513,244
shares
|
$35.4 Million
0.0% of portfolio
|
Q2 2024
Added 16.03%
|
|
|
Logos Global Management LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
2,000,000
shares
|
$28.2 Million
3.97% of portfolio
|
Q1 2025
New holding
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
1,697,557
shares
|
$23.9 Million
0.0% of portfolio
|
Q1 2025
Added 158.46%
|
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
May 15, 2025 Q1 2025 |
1,506,790
shares
|
$21.2 Million
0.69% of portfolio
|
Q1 2025
Added 64.67%
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
May 15, 2025 Q1 2025 |
1,486,461
shares
|
$21 Million
2.81% of portfolio
|
Q1 2025
Added 6294.48%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
1,302,539
shares
|
$18.4 Million
0.0% of portfolio
|
Q1 2025
Added 8.24%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
May 15, 2025 Q1 2025 |
1,263,130
shares
|
$17.8 Million
0.01% of portfolio
|
Q1 2025
Added 10339.95%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
May 08, 2025 Q1 2025 |
1,224,139
shares
|
$17.3 Million
0.03% of portfolio
|
Q1 2025
Added 882.3%
|
|
|
Tang Capital Management LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
1,100,000
shares
|
$15.5 Million
0.73% of portfolio
|
Q1 2025
New holding
|
|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
1,018,734
shares
|
$14.4 Million
0.32% of portfolio
|
Q3 2024
Reduced 19.7%
|
|
|
Alkeon Capital Management LLC
New York, NY |
May 14, 2025 Q1 2025 |
850,511
shares
|
$12 Million
0.02% of portfolio
|
Q1 2025
Reduced 22.75%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
806,185
shares
|
$11.4 Million
0.0% of portfolio
|
Q1 2025
Added 5.32%
|
|
|
Goldman Sachs Group Inc
New York, NY |
May 16, 2025 Q1 2025 |
740,606
shares
|
$10.4 Million
0.0% of portfolio
|
Q1 2025
Added 38.28%
|
|
|
Redmile Group, LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
552,506
shares
|
$7.79 Million
0.59% of portfolio
|
Q1 2024
New holding
|
|
|
Drw Securities, LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
464,895
shares
|
$6.56 Million
0.14% of portfolio
|
Q1 2025
New holding
|
|
|
Rangeley Capital, LLC
New Canaan, CT |
May 14, 2025 Q1 2025 |
408,234
shares
|
$5.76 Million
4.46% of portfolio
|
Q1 2025
New holding
|
|
|
Chi Advisors LLC
New York, NY |
Nov 13, 2023 Q3 2023 |
407,633
shares
|
$5.75 Million
6.41% of portfolio
|
Q3 2023
Added 1.37%
|
|
|
Catalio Capital Management, LP
New York, NY |
May 15, 2025 Q1 2025 |
389,384
shares
|
$5.49 Million
0.97% of portfolio
|
Q1 2025
Reduced 4.4%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
290,011
shares
|
$4.09 Million
0.0% of portfolio
|
Q1 2025
Reduced 2.18%
|
|
|
Pdt Partners, LLC
New York, NY |
May 15, 2025 Q1 2025 |
276,060
shares
|
$3.89 Million
0.22% of portfolio
|
Q1 2025
New holding
|
|
|
Ikarian Capital, LLC
Dallas, TX |
May 15, 2025 Q1 2025 |
274,009
shares
|
$3.86 Million
0.39% of portfolio
|
Q1 2025
New holding
|
|
|
Qube Research & Technologies LTD
London, X0 |
May 15, 2025 Q1 2025 |
273,342
shares
|
$3.85 Million
0.0% of portfolio
|
Q1 2025
New holding
|